We hypothesized that the primary endothelial dysfunction component characterized by an imbalance between sFlt-1 as an angiogenic marker and RAS components (ANG-II and ACE-2) may be related to adverse outcomes in pregnant women with COVID-19. This evidence concerns the gene AGT and COVID-19.